TBP-PI-HBr
SPR994-305
Phase 3 small_molecule completed
Quick answer
TBP-PI-HBr for Urinary Tract Infection is a Phase 3 program (small_molecule) at Spero Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Spero Therapeutics
- Indication
- Urinary Tract Infection
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed